
Nimpod 30mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Nimodipine (30mg)
Overview Nimpod 30mg Tablet
Nimodipine 30mg tablets are prescribed to manage and mitigate further brain injury following a subarachnoid hemorrhage (SAH). This calcium channel blocker enhances cerebral blood flow, thereby reducing the risk of neurological deficits. Treatment with Nimodipine 30mg tablets should commence promptly upon medical confirmation of SAH. Dosage and administration frequency are determined individually by your physician, based on your clinical status and treatment response. The medication may be taken with or without food, but consistent adherence to your prescribed schedule is crucial for optimal efficacy. Avoid antacids within a two-hour window of taking Nimodipine 30mg tablets, as this can impair absorption. Discontinuation of this medication should only occur under your doctor's supervision; premature cessation may exacerbate your condition. Common adverse effects include hypotension, tachycardia, cephalalgia, gastrointestinal upset, nausea, skin rashes, muscle spasms, and generalized edema. Report any persistent, worsening, or bothersome side effects to your physician. Prior to initiating Nimodipine 30mg tablets, disclose any pre-existing cardiac or hepatic issues. Interactions may occur with certain anticonvulsants and medications used to treat hypertension or cardiovascular diseases; therefore, inform your doctor of all current medications. Pregnant or lactating individuals should seek medical counsel before commencing treatment. Your blood pressure will be closely monitored throughout the treatment period.
Uses of Nimpod 30mg Tablet
Bleeding into the subarachnoid space
Major Benefits of Nimpod 30mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 30mg Nimpod tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of Nimpod 30mg Tablet:
- Decreased blood pressure
- Headache
- Increased heart rate
- Nausea
- Rash
- Stomach discomfort
- Edema (swelling)
- Muscle cramp
How to use Nimpod 30mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nimpod 30mg Tablets can be administered with or without food, although consistent timing is recommended.
How Nimpod 30mg Tablet works:
CerebralGuard 30mg tablets, a calcium channel antagonist, dilate constricted intracranial blood vessels, facilitating improved cerebral blood flow. This action mitigates brain injury following subarachnoid hemorrhage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Nimpod 30mg tablets and alcohol may induce significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Nimpod 30mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Nimpod 30mg tablets are likely incompatible. Available evidence from humans indicates potential drug transfer via breastmilk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Nimpod 30mg tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Nimpod 30mg Tablets in individuals with kidney impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Nimpod 30mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Nimpod 30mg Tablet :
NA
Facts to Know About Nimpod 30mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Dihydropyridine carboxylic acid analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Category | Dihydropyridine Calcium Channel Blockers |
